查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1765280

全球治療性血漿置換市場

Therapeutic Plasma Exchange
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2030年，全球治療性血漿置換市場規模將達21億美元

全球治療性血漿置換市場規模預計在2024年為15億美元，到2030年將達到21億美元，在分析期間（2024-2030年）的複合年成長率為6.2%。神經系統疾病是本報告分析的細分市場之一，預計其複合年成長率為6.9%，到分析期結束時將達到7.896億美元。腎臟病學細分市場在分析期間的複合年成長率預計為5.3%。

美國市場規模估計為 4.101 億美元，中國市場預計複合年成長率為 5.7%

美國治療性血漿置換市場規模預計在2024年達到4.101億美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到3.317億美元，在2024-2030年的分析期間內，複合年成長率為5.7%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間的複合年成長率分別為5.5%和5.1%。在歐洲，預計德國的複合年成長率為4.6%。

全球治療性血漿置換市場－主要趨勢與促進因素摘要

為什麼治療性血漿置換在現代醫療保健中如此重要？

治療性血漿置換 (TPE) 已成為治療各種自體免疫、血液疾病和神經系統疾病的救命良方。此方法包括從患者血液中抽取血漿，並以新鮮血漿或血漿代用品取代，從而幫助清除體內有害的抗體和毒素。 TPE 在Guillain-Barré二氏症候群、重症肌無力、多發性硬化症等疾病的治療中日益普及，凸顯了其在醫療保健領域的重要角色。隨著人們對血漿置換益處的認知不斷提高，越來越多的患者和醫療保健提供者開始利用這種療法，近年來，治療性血漿置換市場規模顯著擴張。

不同的應用和技術如何推動市場？

從技術角度來看，離心和薄膜過濾是最常用的方法，每種方法各有優點。離心系統廣泛應用於神經系統疾病的治療，而膜過濾較適用於腎臟疾病和某些血液系統疾病的治療。其適應症涵蓋從自體免疫疾病到血液系統疾病以及其他嚴重疾病。從最終用戶來看，醫院、專科診所和捐血中心佔據市場主導地位，越來越多的門診病人機構採用TPE程序進行慢性疾病管理。越來越多的採用TPE的治療方案正在擴大整體市場規模。

哪些創新正在塑造治療性血漿置換的未來？

技術進步帶來了更有效率、更安全、更方便的血漿置換系統，使醫療保健提供者更容易獲得血漿置換。安全性更高的自動血漿分離機正日益成為醫療照護的標準，從而縮短了手術時間並改善了患者的預後。此外，TPE 系統整合的即時監控和數據分析功能使醫療保健提供者能夠根據患者的具體情況量身定做治療方案。此外，將 TPE 與免疫抑制療法等其他治療方法結合的趨勢日益成長，這正在改變慢性病管理的面貌。

哪些因素推動了治療性血漿置換市場的成長？

治療性血漿置換市場的成長受到多種因素的推動，例如自體免疫疾病盛行率的上升、TPE 在神經系統疾病治療中的應用日益廣泛，以及新型血漿置換設備核准數量的不斷增加。血漿分離設備的技術創新，加上醫療基礎設施投資的不斷增加，正在擴大 TPE 的應用範圍。此外，醫護人員越來越意識到在嚴重監護環境中使用 TPE 進行早期療育的益處，這也推動了血漿置換的需求。符合 TPE 條件的患者群體不斷擴大，尤其是在治療罕見和複雜疾病方面，這進一步推動了市場的成長。最後，攜帶式且經濟高效的血漿置換系統的開發，使這種救命療法更加普及，預計將在未來幾年推動市場發展。

部分

適應症（神經、腎臟、血液、代謝、其他）、最終用途（醫院、專科診所、門診手術中心）

受訪公司範例

  • Asahi Kasei Medical Co., Ltd.
  • B. Braun Melsungen AG
  • Baxter International, Inc.
  • Fenwal, Inc.
  • Fresenius SE & Co. KGaA
  • Haemonetics Corporation
  • HemaCare Corporation
  • Kawasumi Laboratories, Inc.
  • Terumo BCT, Inc.

人工智慧整合

我們正在利用可操作的專家內容和人工智慧工具來改變市場和競爭情報。

Global 特定產業SLM 的典型規範，而是建立了一個從全球專家收集的內容庫，其中包括視訊錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地、進出口狀況（成品和原始OEM）預測其競爭態勢的變化。這種複雜且多面向的市場動態預計將以多種方式影響競爭對手，包括銷貨成本成本 (COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他地區

第4章 競賽

簡介目錄
Product Code: MCP15189

Global Therapeutic Plasma Exchange Market to Reach US$2.1 Billion by 2030

The global market for Therapeutic Plasma Exchange estimated at US$1.5 Billion in the year 2024, is expected to reach US$2.1 Billion by 2030, growing at a CAGR of 6.2% over the analysis period 2024-2030. Neurological Disorders, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$789.6 Million by the end of the analysis period. Growth in the Renal Disorders segment is estimated at 5.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$410.1 Million While China is Forecast to Grow at 5.7% CAGR

The Therapeutic Plasma Exchange market in the U.S. is estimated at US$410.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$331.7 Million by the year 2030 trailing a CAGR of 5.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.5% and 5.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.6% CAGR.

Global Therapeutic Plasma Exchange Market - Key Trends and Drivers Summarized

What Makes Therapeutic Plasma Exchange Critical in Modern Healthcare?

Therapeutic plasma exchange (TPE) has emerged as a life-saving procedure in treating various autoimmune diseases, hematological conditions, and neurological disorders. This procedure involves the removal of plasma from a patient's blood and its replacement with fresh plasma or a plasma substitute, which helps eliminate harmful antibodies and toxins. The increasing use of TPE in treating conditions such as Guillain-Barre syndrome, myasthenia gravis, and multiple sclerosis has underscored its critical role in healthcare. As awareness of the benefits of plasma exchange grows, more patients and healthcare providers are turning to this therapy, which has significantly expanded the therapeutic plasma exchange market in recent years.

How Are Different Applications and Technologies Driving the Market?

By technology, centrifugal-based and membrane filtration techniques are the most commonly employed methods, each offering distinct advantages. Centrifugal-based systems are widely used in treating neurological conditions, whereas membrane filtration is preferred for renal disorders and certain hematological diseases. Disease indication segments range from autoimmune disorders to blood dyscrasias and other critical illnesses. In terms of end-users, hospitals, specialty clinics, and blood donation centers dominate the market, with a growing number of outpatient facilities adopting TPE procedures for chronic disease management. The rising number of treatment options that incorporate TPE is expanding the market’s overall reach.

What Innovations Are Shaping the Future of Therapeutic Plasma Exchange?

Technological advancements have led to more efficient, safe, and user-friendly plasma exchange systems, making the procedure more accessible to healthcare providers. Automated apheresis devices, equipped with enhanced safety features, are increasingly becoming the standard of care, reducing procedure time and improving patient outcomes. Moreover, the integration of real-time monitoring and data analytics in TPE systems allows healthcare providers to customize treatments based on patient-specific conditions. Additionally, the growing trend of combining therapeutic plasma exchange with other treatment modalities, such as immunosuppressive therapies, is transforming the landscape of chronic disease management.

What Are the Key Drivers of Growth in the Therapeutic Plasma Exchange Market?

The growth in the therapeutic plasma exchange market is driven by several factors, including the rising prevalence of autoimmune diseases, the increased use of TPE in treating neurological conditions, and the growing number of regulatory approvals for novel plasma exchange devices. Technological innovations in apheresis devices, coupled with rising investments in healthcare infrastructure, are expanding the adoption of TPE. Additionally, increasing awareness among healthcare professionals about the benefits of early intervention with TPE in critical care settings is boosting the demand for plasma exchange. The expanding base of patients eligible for TPE, particularly in the treatment of rare and complex disorders, further propels market growth. Lastly, the development of portable and more cost-effective plasma exchange systems is expected to make this life-saving therapy more accessible, driving market expansion in the coming years.

SCOPE OF STUDY:

The report analyzes the Therapeutic Plasma Exchange market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Disease Indication (Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders, Other Disease Indications); End-Use (Hospitals, Specialty Clinics, Ambulatory Surgery Centers)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 47 Featured) -

  • Asahi Kasei Medical Co., Ltd.
  • B. Braun Melsungen AG
  • Baxter International, Inc.
  • Fenwal, Inc.
  • Fresenius SE & Co. KGaA
  • Haemonetics Corporation
  • HemaCare Corporation
  • Kawasumi Laboratories, Inc.
  • Terumo BCT, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Global Economic Update
    • Therapeutic Plasma Exchange - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Incidence of Autoimmune Diseases Propels Growth of Therapeutic Plasma Exchange Market
    • Rising Demand for Non-invasive Therapeutic Solutions Strengthens Adoption of Plasma Exchange
    • Increasing Application of Therapeutic Plasma Exchange in Neurological Disorders Expands Market Opportunity
    • Advances in Medical Device Technologies Drive the Efficiency of Plasma Exchange Systems
    • Growing Use of Therapeutic Plasma Exchange in Pediatric Applications Spurs Market Growth
    • Rising Focus on Plasma-based Treatments for Critical Illnesses Drives Adoption of Therapeutic Plasma Exchange
    • Technological Innovations in Apheresis Systems Generate Demand for Advanced Plasma Exchange Solutions
    • Increased Awareness of Plasma Donation Programs Expands Adoption of Plasma Exchange Treatments
    • Growing Number of Plasma Collection Centers Propels the Therapeutic Plasma Exchange Market
    • Integration of AI and Data Analytics in Plasma Exchange Systems Strengthens Operational Efficiency
    • Surge in Clinical Trials Exploring Plasma Exchange for Emerging Therapies Boosts Market Demand
    • Increasing Use of Plasma Exchange in Immunology and Hematology Drives Market Expansion
    • Rising Prevalence of Infectious Diseases Spurs Demand for Plasma-based Therapies
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Therapeutic Plasma Exchange Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Therapeutic Plasma Exchange by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Therapeutic Plasma Exchange by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Neurological Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Neurological Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Neurological Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Renal Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Renal Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Renal Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hematology Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hematology Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Hematology Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Metabolic Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Metabolic Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Metabolic Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other Disease Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other Disease Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Other Disease Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Specialty Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Therapeutic Plasma Exchange Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Therapeutic Plasma Exchange by Disease Indication - Percentage Breakdown of Value Sales for Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Therapeutic Plasma Exchange by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Therapeutic Plasma Exchange by Disease Indication - Percentage Breakdown of Value Sales for Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Therapeutic Plasma Exchange by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • JAPAN
    • Therapeutic Plasma Exchange Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Therapeutic Plasma Exchange by Disease Indication - Percentage Breakdown of Value Sales for Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Japan 15-Year Perspective for Therapeutic Plasma Exchange by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • CHINA
    • Therapeutic Plasma Exchange Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Therapeutic Plasma Exchange by Disease Indication - Percentage Breakdown of Value Sales for Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: China 15-Year Perspective for Therapeutic Plasma Exchange by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • EUROPE
    • Therapeutic Plasma Exchange Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Therapeutic Plasma Exchange by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Therapeutic Plasma Exchange by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Therapeutic Plasma Exchange by Disease Indication - Percentage Breakdown of Value Sales for Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for Therapeutic Plasma Exchange by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • FRANCE
    • Therapeutic Plasma Exchange Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Therapeutic Plasma Exchange by Disease Indication - Percentage Breakdown of Value Sales for Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: France 15-Year Perspective for Therapeutic Plasma Exchange by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • GERMANY
    • Therapeutic Plasma Exchange Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Therapeutic Plasma Exchange by Disease Indication - Percentage Breakdown of Value Sales for Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Germany 15-Year Perspective for Therapeutic Plasma Exchange by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Therapeutic Plasma Exchange by Disease Indication - Percentage Breakdown of Value Sales for Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Italy 15-Year Perspective for Therapeutic Plasma Exchange by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Therapeutic Plasma Exchange Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Therapeutic Plasma Exchange by Disease Indication - Percentage Breakdown of Value Sales for Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: UK 15-Year Perspective for Therapeutic Plasma Exchange by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Europe Historic Review for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Rest of Europe 15-Year Perspective for Therapeutic Plasma Exchange by Disease Indication - Percentage Breakdown of Value Sales for Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 15-Year Perspective for Therapeutic Plasma Exchange by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Therapeutic Plasma Exchange Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific Historic Review for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Asia-Pacific 15-Year Perspective for Therapeutic Plasma Exchange by Disease Indication - Percentage Breakdown of Value Sales for Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 15-Year Perspective for Therapeutic Plasma Exchange by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of World Historic Review for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of World 15-Year Perspective for Therapeutic Plasma Exchange by Disease Indication - Percentage Breakdown of Value Sales for Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 101: Rest of World Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Rest of World Historic Review for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Rest of World 15-Year Perspective for Therapeutic Plasma Exchange by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030

IV. COMPETITION